Location History:
- Montgomery Village, MD (US) (2009 - 2012)
- Frederick, MD (US) (2014)
Company Filing History:
3 out of 3,539 
1 out of 15 Years Active: 2009-2014
Title: Yili Yang: Innovator in Cancer Treatment
Introduction
Yili Yang is a notable inventor based in Montgomery Village, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 3 patents, his work has the potential to impact the lives of many patients.
Latest Patents
Yili Yang's latest patents include innovative compounds designed to improve cancer treatment. One of his notable inventions is the "Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer." This invention features pyrimido-dione-quinoline compounds that exhibit improved solubility, along with pharmaceutical compositions and methods for treating patients suffering from cancer. The method involves administering one or more of these compounds to patients. Another significant patent is for "Inhibitors of ubiquitin E1," which includes pyrazolidinyl compounds and their pharmaceutical compositions. This invention also focuses on methods for treating patients suffering from cancer or viral infections by administering these compounds.
Career Highlights
Throughout his career, Yili Yang has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Bioveris Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Yili Yang has collaborated with several notable individuals in his field, including Allan M. Weissman and Jane P. Jensen. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yili Yang is a prominent inventor whose work in developing compounds for cancer treatment showcases his dedication to improving patient outcomes. His innovative patents and collaborations highlight his significant contributions to the pharmaceutical industry.